|
Manhattan Bridge Capital, Inc. (LOAN): BCG Matrix [Dec-2025 Updated] |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Manhattan Bridge Capital, Inc. (LOAN) Bundle
You're looking to map the current strategic health of Manhattan Bridge Capital, Inc.'s hard money lending business as we head into late 2025, and honestly, the picture is a classic mix of established strength and necessary future bets. We've broken down their portfolio using the BCG Matrix, showing where their high-yield construction financing Stars, potentially generating over 12%, are fueling the reliable income from their core Cash Cows, while also highlighting the capital-draining Dogs and the crucial, yet uncertain, Question Marks like their expansion into Northern New Jersey. Dive in below to see exactly where Manhattan Bridge Capital, Inc. needs to focus its capital-whether to milk the reliable assets or aggressively fund the next big growth area.
Background of Manhattan Bridge Capital, Inc. (LOAN)
Manhattan Bridge Capital, Inc. (LOAN) is a real estate finance company operating as a real estate investment trust (REIT) headquartered in Great Neck, New York. You'll find them publicly traded on the NASDAQ-CM exchange. The core business objective is to grow the loan portfolio while preserving capital to deliver attractive risk-adjusted returns to shareholders.
Manhattan Bridge Capital, Inc. specializes in originating, servicing, and managing a portfolio of first mortgage loans. Specifically, they offer short-term, secured, non-banking loans, often called 'hard money' loans, to real estate investors. These loans fund the acquisition, renovation, or development of residential or commercial properties.
The company's primary geographical focus centers on the New York metropolitan area, including New Jersey and Connecticut, but they also have exposure in Florida. Their typical loan terms are short, with a maximum initial term of 12 months, and they generally charge interest rates between 9% to 13%.
Looking at the recent performance, for the nine months ended September 30, 2025, Manhattan Bridge Capital, Inc. reported total revenues of approximately $6,665,000, which was a decrease of 9.1% compared to the $7,330,000 generated in the same period of 2024. This revenue dip was mainly due to lower interest income from a reduction in loans receivable and reduced origination fees, despite a slowdown in new loan originations.
For the third quarter of 2025, the net income came in around $1,202,000, or $0.11 per basic and diluted share, a slight dip from the $1,399,000 reported in the third quarter of 2024. As of September 30, 2025, the total stockholders' equity stood at approximately $43,317,000.
As of late November 2025, the company's market capitalization was reported at $51.59 million. Furthermore, the Chairman and CEO, Assaf Ran, announced on November 20, 2025, that the Board authorized a share buy back program for up to 100,000 common shares, reflecting management's confidence in the business prospects.
Manhattan Bridge Capital, Inc. (LOAN) - BCG Matrix: Stars
You're analyzing the core engine of Manhattan Bridge Capital, Inc.'s current success, the segment that demands investment to maintain its leadership position. This is where the high-growth market meets the company's strong niche capture.
This Star segment centers on short-term construction financing aimed at small-scale residential flips within the high-demand boroughs of New York City. These are high-interest, first-lien bridge loans targeting properties showing rapid value appreciation potential. The market itself is characterized by strong underlying demand, evidenced by the persistent housing shortage in the United States, estimated to be 4.5 million homes and growing. Furthermore, in key outer boroughs like Brooklyn, property values are projected to appreciate between 15-20% through 2025, and Queens is seeing projections of 12-15% value increases in areas like Long Island City and Astoria. These appreciation rates signal a high-growth environment for the underlying assets.
Manhattan Bridge Capital, Inc. maintains a strong niche position here, as shown by its recent financial output. For the three months ended March 31, 2025, the interest income generated from secured commercial loans-which includes this segment-was approximately $1,834,000. This was supplemented by origination fees of approximately $440,000 in the same quarter. The total revenue for that quarter reached approximately $2,274,000. The company's CEO noted concerns about the real estate market recovery due to interest rate delays, yet the segment's performance remains strong enough to be classified as a Star, consuming cash to maintain its market share in a growing space.
The strategic goal is to sustain this market share so these operations mature into Cash Cows when the high-growth market eventually slows. A key tenet of the Boston Consulting Group strategy here is to continue investing heavily in promotion and placement for these leading products. While the target yield for these high-yield loans is often above 12%, the actual performance is tied to the successful execution of the underlying real estate projects.
Here is a snapshot of the recent financial contribution that defines this segment's Star status:
| Metric | Value (3 Months Ended 3/31/2025) | Context |
|---|---|---|
| Interest Income from Secured Loans | $1,834,000 | Primary revenue driver for the segment |
| Origination Fees on Loans | $440,000 | Secondary revenue stream |
| Total Revenue (All Segments) | $2,274,000 | Overall quarterly top-line result |
| Net Income (All Segments) | $1,373,000 | Profitability for the quarter |
The high-growth nature of the market is further supported by the general strength in related real estate sectors, such as rental rates in NYC being up 30-40% compared to 2023 levels, which supports the underlying property values that Manhattan Bridge Capital, Inc. finances.
You should focus on the capital deployment necessary to keep this segment ahead of emerging competitors. Key areas for continued investment support include:
- Maintaining underwriting standards against potential market softening.
- Securing prime deal flow in high-appreciation boroughs.
- Ensuring placement speed to maximize asset turnover.
- Supporting borrower relationships despite economic uncertainty.
For the third quarter of 2025, the company reported an Earnings Per Share of $0.11 on quarterly revenue of $2.04 million, illustrating the ongoing operational scale of the business units, including this leading segment.
Manhattan Bridge Capital, Inc. (LOAN) - BCG Matrix: Cash Cows
Manhattan Bridge Capital, Inc. (LOAN) operates its core business as a Cash Cow, characterized by a high market share in a mature, localized segment, generating predictable cash flow to support the entire enterprise.
Core portfolio of established, short-term first-mortgage loans on non-owner-occupied properties. This forms the bedrock of the company's operations, providing consistent returns from existing assets rather than requiring heavy investment in new market penetration.
Consistent interest income stream from a mature, low-growth NYC real estate market segment. For the nine months ended September 30, 2025, revenues of approximately $5,504,000 were attributable to interest income on secured commercial loans. This stability is key to the Cash Cow designation.
High market share in the specific, localized NYC hard money lending niche. While exact market share percentages are proprietary, the company's sustained profitability and dividend history in this specialized area suggest a strong, established position. The focus remains on maintaining this existing book.
Reliable source for the company's consistent dividend payments to shareholders. Manhattan Bridge Capital, Inc. (LOAN) has a history of regular quarterly payouts. The last recorded dividend per share was $0.115, with an upcoming ex-dividend date of December 31, 2025, for a payment of $0.115 per share. The Trailing Twelve Months (TTM) dividend was $0.46 per share. This commitment is supported by earnings, though the TTM payout ratio was 97.87%.
Low capital expenditure needed to maintain this existing, well-managed loan book. The model relies on servicing existing loans, meaning promotional spending is minimal, allowing most generated cash to flow upward. The company's total stockholders' equity stood at approximately $43,317,000 as of September 30, 2025, representing the strong asset base supporting these cash flows.
Here's the quick math on the core revenue drivers for the nine months ended September 30, 2025:
| Revenue Source | Amount (USD) | Percentage of Total Revenue |
| Interest Income on Secured Commercial Loans | Approximately $5,504,000 | Approximately 82.7% |
| Origination Fees on Loans | Approximately $1,161,000 | Approximately 17.3% |
The Cash Cow quadrant is where the company harvests value to fund other areas. The profitability from this segment is evident in the net income figures.
- Net Income (Three Months Ended Sept 30, 2025): Approximately $1,202,000.
- Net Income (Nine Months Ended Sept 30, 2025): Approximately $3,988,000.
- Weighted-Average Shares Outstanding (2025): Approximately 11.4 million.
- GAAP EPS (Q3 2025): $0.11.
- Current Share Price (as of Nov 4, 2025): $4.920.
The strategy here is to maintain the loan book quality and operational efficiency. Investments are targeted at infrastructure that improves servicing efficiency, not market expansion. The focus is on milking the gains passively, ensuring the dividend remains secure, which is a primary goal for Manhattan Bridge Capital, Inc. (LOAN) shareholders.
Manhattan Bridge Capital, Inc. (LOAN) - BCG Matrix: Dogs
Dogs are units or products with a low market share and low growth rates. They frequently break even, neither earning nor consuming much cash. Dogs are generally considered cash traps because businesses have money tied up in them, even though they bring back almost nothing in return. These business units are prime candidates for divestiture.
For Manhattan Bridge Capital, Inc. (LOAN), the 'Dogs' quadrant likely encompasses assets or loan vintages that are underperforming relative to the current market environment, characterized by low yield or high administrative drag. While specific 2025 figures for Non-Performing Assets (NPAs) or Foreclosed Real Estate Owned (REO) are not explicitly itemized in the latest disclosures, the general trend of revenue contraction points to areas needing scrutiny.
The overall revenue decline for the nine months ended September 30, 2025, was $\mathbf{9.1\%}$ year-over-year, totaling approximately $\mathbf{\$6,665,000}$. This was primarily attributed to lower interest income, which for the same nine-month period was approximately $\mathbf{\$5,504,000}$ in 2025, down from $\mathbf{\$6,128,000}$ in 2024. This reduction in interest income from the loan portfolio signals that a portion of the assets may be categorized as Dogs due to low current yields or slow turnover.
You should focus your review on these specific categories:
- Any legacy non-performing assets (NPAs) or foreclosed real estate owned (REO) requiring significant management time.
- Low-yield loans originated during periods of lower interest rates that are still on the books.
- Loans in geographically peripheral or economically stagnant areas outside the core NYC metro.
- High-risk, low-return loans that tie up capital without contributing meaningfully to net interest income.
The action taken on legacy debt provides a concrete example of managing past obligations. Manhattan Bridge Capital, Inc. announced the full redemption of $\mathbf{\$6,000,000}$ aggregate principal amount of 6.00% Senior Secured Notes due April 22, 2026, scheduled for December 15, 2025. This move removes a fixed $\mathbf{6.00\%}$ annual interest obligation from the capital structure.
The following table outlines key financial metrics from the nine months ended September 30, 2025, which provide the context for evaluating asset performance. Note that the specific breakdown of the loan portfolio into the four Dog categories is not publicly itemized, so these figures represent the entire revenue-generating base impacted by these dynamics.
| Metric (Nine Months Ended Sept 30, 2025) | Value | Comparison to Prior Year (9M Ended Sept 30, 2024) |
|---|---|---|
| Total Revenues | $\mathbf{\$6,665,000}$ | Decreased by $\mathbf{9.1\%}$ |
| Interest Income from Secured Loans | $\mathbf{\$5,504,000}$ | Decrease from $\mathbf{\$6,128,000}$ |
| Origination Fees Revenue | $\mathbf{\$1,161,000}$ | Decrease from $\mathbf{\$1,201,000}$ |
| Net Income | $\mathbf{\$3,988,000}$ | Decrease of $\mathbf{6.9\%}$ |
| Total Stockholders' Equity (as of Sept 30) | $\mathbf{\$43,317,000}$ | Context for capital base |
Expensive turn-around plans usually do not help, so divestiture or aggressive management of these low-performing assets is the typical strategy. The reduction in loans receivable, which contributed to the Q2 2025 revenue decline of $\mathbf{3.6\%}$ to $\mathbf{\$2,355,000}$, suggests capital is not being redeployed into higher-yielding assets quickly enough, or that existing assets are maturing/paying down without immediate replacement by comparable quality loans. Honestly, you want to see the specific write-downs or reserves against potential losses tied to these Dog categories, which aren't explicitly stated in the top-line results.
Manhattan Bridge Capital, Inc. (LOAN) - BCG Matrix: Question Marks
You're hiring before product-market fit, and that's exactly where Manhattan Bridge Capital, Inc.'s Question Marks reside. These are the business efforts with high growth prospects but, as of the latest figures, a low relative market share, meaning they consume cash without delivering proportional returns yet. For Manhattan Bridge Capital, Inc., these units are likely centered on newer geographic pushes or evolving loan product types.
The core business remains short-term, secured, non-banking loans, primarily in the established New York metropolitan area, New Jersey, Connecticut, and Florida. The Question Marks are where management is placing capital to secure future growth, hoping these ventures transition into Stars. These areas require significant capital investment and management focus to prove they can capture market share quickly.
The strategy here involves heavy investment to gain traction or a decision to divest if the growth potential doesn't materialize soon. The financial reality for the nine months ended September 30, 2025, shows Total Revenue at $6.665 million, with Net Income for the same period at $3.988 million. This must be weighed against the capital deployed in these potentially nascent areas.
The focus on expanding the loan product mix is a clear indicator of a Question Mark strategy. While the company has a long history in secured loans, the push into specific commercial segments represents a growth area where market share is not yet dominant.
- Small-scale geographic expansion into adjacent, high-growth markets like Northern New Jersey or specific Connecticut submarkets.
- New product lines, such as commercial bridge loans or larger-ticket institutional co-lending opportunities.
- Low market share in these new ventures, but the overall market growth potential is high.
- Requires significant capital investment and management focus to see if they can gain market share and become Stars.
The data suggests a significant deployment of capital into commercial lending activities, which, relative to the overall revenue decline seen in Q3 2025, might represent the cash drain characteristic of a Question Mark. For the nine months ended September 30, 2025, Manhattan Bridge Capital, Inc. issued approximately $27,957,000 in commercial loans, while Total Revenue for the same period was $6.665 million. This disparity highlights the investment phase.
Here's a quick look at the scale of operations as of September 30, 2025, contrasting the overall portfolio size with the recent commercial loan activity:
| Metric | Value (As of Sept 30, 2025 TTM or Period End) | Context |
|---|---|---|
| Total Assets (In Thousands, USD) | $59,989 | Overall balance sheet size. |
| Total Debt (In Thousands, USD) | $15,185 | Total leverage supporting the portfolio. |
| Commercial Loans Issued (9 Months Ended) | $27,957,000 | Volume in the potentially high-growth segment. |
| Q3 2025 Net Income | $1.202 million | Current return on invested capital. |
| Total Shareholders' Equity (As of June 30, 2025) | $43.4 million | Capital base available for investment. |
The company's stated lending policy limits the maximum loan amount to the lower of 9.9% of the aggregate loan portfolio or $4 million as of the 2024 year-end, which suggests that even within the commercial segment, individual loan sizes are capped, potentially limiting immediate high-return scaling unless the portfolio itself grows rapidly. The recent stock repurchase authorization of up to 100,000 shares in November 2025, following a stock price of $5.22 on October 24, 2025, might signal management's belief that the current valuation does not reflect the potential of these growth areas, or it could be a defensive move while these ventures mature.
These Question Marks are consuming cash flow, as evidenced by the Q3 2025 Total Revenue of $2.036 million, a 12.0% decrease compared to the same period in 2024. The path forward for these segments is clear: either significant investment is made to rapidly increase their market share and generate returns that push them toward Star status, or they risk becoming Dogs if growth stalls.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.